Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anaplastic thyroid carcinoma
|
16 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 34 | 2006 | 2019 | ||||||
Adenocarcinoma
|
168 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 20 | 2006 | 2019 | ||||||
Malignant neoplasm of lung
|
1142 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 1.000 | 10 | 2006 | 2020 | ||||||
Hyperplastic Polyp
|
22 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.090 | 1.000 | 9 | 2006 | 2016 | ||||||
Melanocytic nevus of skin
|
3 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.080 | 1.000 | 8 | 2006 | 2019 | ||||||
Follicular thyroid carcinoma
|
28 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.060 | 1.000 | 6 | 2006 | 2018 | ||||||
Anaplasia
|
7 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2016 | ||||||
Carcinoma of lung
|
1204 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||
Progressive cGVHD
|
40 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||
Progressive Neoplastic Disease
|
40 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2018 | ||||||
Secondary malignant neoplasm of lung
|
20 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2006 | 2015 | ||||||
Follicular Variant Thyroid Gland Papillary Carcinoma
|
13 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.030 | 0.667 | 3 | 2006 | 2018 | ||||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Malignant melanoma of choroid
|
5 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Merkel cell carcinoma
|
10 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.010 | 1 | 2006 | 2006 | |||||||
premalignant lesion
|
5 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Tumor Cell Invasion
|
169 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.927 | 41 | 2007 | 2018 | ||||||
Carcinoma, Papillary
|
9 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.100 | 0.900 | 10 | 2007 | 2018 | ||||||
Turcot syndrome (disorder)
|
75 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.070 | 1.000 | 7 | 2007 | 2019 | ||||||
Malignant neoplasm of ovary
|
315 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.060 | 1.000 | 6 | 2007 | 2015 | ||||||
Carcinoma, Ovarian Epithelial
|
327 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.050 | 1.000 | 5 | 2007 | 2015 | ||||||
MSI-high
|
9 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.030 | 1.000 | 3 | 2007 | 2015 | ||||||
Carcinoma, Endometrioid
|
12 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.020 | 1.000 | 2 | 2007 | 2013 | ||||||
Serous cystadenoma, borderline malignancy
|
2 | 0.354 | 0.840 | 7 | 140753335 | missense variant | CA/AT;TT | mnv | 0.020 | 1.000 | 2 | 2007 | 2018 |